Stonepine Capital Management
BOLD icon

Stonepine Capital Management’s Boundless Bio BOLD Stock Holding History

Stonepine Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$132K Sell
52,547
-102,048
-66% -$275K 0.08% 72
2026
Q2 		$386K Sell
154,595
-443,087
-74% -$682K 0.22% 67
2026
Q1 		$657K Sell
597,682
-112,389
-16% -$131K 0.26% 49
2025
Q4 		$852K Buy
710,071
+296,618
+72% +$370K 0.62% 40
2025
Q3 		$509K Buy
413,453
+307,278
+289% +$355K 0.41% 41
2025
Q2 		$107K Buy
+106,175
New +$141K 0.11% 58

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
RBF Capital
RBF Capital San Francisco, California $2.3B AUM 22.6% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Stonepine Capital Management's BOLD Position: Q3 2026 in Review

Stonepine Capital Management reduced its Boundless Bio (BOLD) stake by 66% in Q3 2026, selling an estimated $275K and leaving 52,547 shares worth $132K. The position accounts for 0.08% of the portfolio, ranked #72.

Stonepine Capital Management first reported a position in BOLD in Q2 2025 and has held it in 6 quarters since. The position peaked at $852K in Q4 2025. 25 funds tracked by Wall St. Rank hold BOLD as of Q3 2026.

  • Stonepine Capital Management held 52,547 shares of Boundless Bio worth $132K as of Q3 2026.
  • Stonepine Capital Management sold 102,048 Boundless Bio shares in Q3 2026, an estimated $275K.
  • Boundless Bio made up 0.08% of Stonepine Capital Management's portfolio in Q3 2026, its #72 holding.
  • Stonepine Capital Management first reported a position in Boundless Bio in Q2 2025 and has held it in 6 quarters since.
  • Stonepine Capital Management's Boundless Bio position peaked at $852K in Q4 2025.
  • 25 funds tracked by Wall St. Rank held Boundless Bio as of Q3 2026.

Based on Stonepine Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.